UPPSALA, Sweden, Oct. 7, 2025 /PRNewswire/ -- Beactica Therapeutics AB, the Swedish precision medicine company, today announced that it has conducted a first scientific advisory meeting with the Swedish Medical Products Agency regarding the drug candidate BEA-17. Specifically, the...
Hence then, the article about beactica conducts first advisory meeting with the swedish medical products agency regarding the development of bea 17 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Beactica conducts first advisory meeting with the Swedish Medical Products Agency regarding the development of BEA-17 )
Also on site :
- Grimes to Star in the First-Ever AI-Generated Film Coming to Theaters: Watch a Clip
- What ‘Legend of Zelda’ Superfan Jon Batiste Thinks of ‘Ocarina of Time’ Remake and the Game’s Iconic Score
- Thousands of affidavit ballots outstanding in Mississippi Senate election. Campaigns prepare for legal fight